Keywords: neurex, licenses, corlopam, french, firm, deal, worth

Neurex Licenses Corlopam To French Firm

Article | 07 October 1996

Print This

- In a deal worth up to $7.5 million in licensing fees and milestone payments, Neurex has licensed the intravenous and alternative ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in